Glial and neuronal tau pathology in tauopathies: Characterization of disease-specific phenotypes and tau pathology progression

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 1, 2014, Pages 81-97

  Ferrer, Isidre ^a   López González, Irene ^a   Carmona, Margarita ^a   Arregui, Laura ^a   Dalfó, Esther ^b   Torrejón Escribano, Benjamin ^c   Diehl, Roberta ^d,e   Kovacs, Gabor G ^f  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Neurometabolic Diseases Laboratory   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e Sao Paulo Brain Bank ^*  (Brazil)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

1 Joshua; Astrocyte; Dementia; Glial inclusion; Immunohistochemistry; Neurodegeneration; Oligodendrocyte; Tauopathes; Wisell

Indexed keywords

TAU PROTEIN;

AMINO ACID SEQUENCE; ARGYROPHILIC GRAIN DISEASE; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN TISSUE; CLINICAL ARTICLE; COILED BODY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DISEASE CLASSIFICATION; DISEASE COURSE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GLIA CELL; GLOBULAR GLIAL TAUOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIA; PATHOGENESIS; PHENOTYPE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; TAUOPATHY; UBIQUITINATION;

EID: 84891831616     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000030     Document Type: Article

References (50)

1. Buée Scherrer V, Hof PR, Buée L, et al. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 1996;91:351-9 (Pubitemid 26088970)
2. Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999;9:681-93 (Pubitemid 29470961)
3. Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002;61:547-6 (Pubitemid 34603003)
4. Tolnay M, Sergeant N, Ghestem A, et al. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol 2002;104:425-34 (Pubitemid 36075409)
5. Dickson DW, Ahmed Z, Algom AA, et al. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010;23:394-400
6. Kouri N, Whitwell JL, Josephs KA, et al. Corticobasal degeneration: A pathologically distinct 4R tauopathy. Nat Rev Neurol 2011;7:263-372
7. Ghetti B, Hutton ML, Wszolek ZK. Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17). In: Dickson D, ed. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel: ISN Neuropathol Press, 2003:86-102
8. Hogg M, Grujic ZM, BakerM, et al. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathol 2003;106:323-36 (Pubitemid 37265312)
9. Muñoz DG, Ferrer I. Neuropathology of hereditary forms of frontotemporal dementia and parkinsonism. In: Duyckaerts C, Litvan I, eds. Handbook of Clinical Neurology: Dementias. Edinburgh, London, New York, Oxford, Philadelphia, St. Louis, Sydney, Toronto: Elsevier, 2008:393-414
10. Goedert M, Spillantini MG. Pathogenesis of the tauopathies. J Mol Neurosci 2011;45:425-31
11. Dickson DW, Kouri N,MurrayME, et al. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-Tau). J Mol Neurosci 2011;45:384-9
12. Togo T, Dickson DW. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol 2002;104:398-402 (Pubitemid 36075405)
13. Ferrer I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain 2008;146:1640-51
14. Iwasaki Y, Yoshida M, Hattori M, et al. Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy. Acta Neuropathol 2004;108:399-405 (Pubitemid 39462351)
15. Ikeda K, Akiyama H, Kondo H, et al. Thorn-shaped astrocytes: Possibly secondarily induced tau-positive glial fibrillary tangles. Acta Neuropathol 1995;90:620-5
16. Schultz C, Ghebremedhin E, Del Tredici K, et al. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe. Neurobiol Aging 2004;25:397-405 (Pubitemid 38220974)
17. Takeda N, Kishimoto Y, Yokota O. Pick's disease. Adv Exp Med Biol 2012;724:300-16
18. Arima K, Nakamura M, Sunohara N, et al. Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol 1997;93:558-66 (Pubitemid 27239244)
19. Arima K. Ultrastructural characteristics of tau filaments in tauopathies: Immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 2006;26:475-83 (Pubitemid 44454421)
20. Spillantini MG, Goedert M, Crowther RA, et al. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997;94:4113-8 (Pubitemid 27180508)
21. Bird TD, Nochlin D, Poorkaj P, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999;122:741-56 (Pubitemid 29158780)
22. Spina S, Farlow MR, Unverzagt FW, et al. The tauopathy associated with mutation +3 in intron 10 of Tau: Characterization of the MSTD family. Brain 2008;131:72-89
23. Zarranz JJ, Ferrer I, Lezcano E, et al. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 2005; 64:1578-85 (Pubitemid 40617694)
24. Bigio EH, Lipton AM, Yen SH, et al. Frontal lobe dementia with novel tauopathy: Sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol 2001;60:328-41 (Pubitemid 32274048)
25. Ahmed Z, Doherty KM, Silveira-Moriyama L, et al. Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: An emerging group of 4-repeat tauopathies. Acta Neuropathol 2011;122:415-28
26. Kovacs GG, Majtenyi K, Spina S, et al. White matter tauopathy with globular glial inclusions: A distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 2011;67:963-75
27. Kovacs GG, Molnár K, Lászlo L, et al. A peculiar constellation of tau pathology defines a subset of dementia in the elderly. Acta Neuropathol 2011;122:205-22
28. Garc?́a-Sierra F, Ghoshal N, Quinn B, et al. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimers Dis 2003;5:65-77 (Pubitemid 36582767)
29. Luna-Muñoz J, Garc?́a-Sierra F, Falcón V, et al. Regional conformational change involving phosphorylation of tau protein at the Thr231 precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. J Alzheimers Dis 2005;8:29-41 (Pubitemid 41267321)
30. Luna-Muñoz J, Chávez-Mac?́as L, Garc?́a-Sierra F, et al. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. J Alzheimers Dis 2007;12:365-75
31. Mondragón-Rodr?́guez S, Basurto-Islas G, Santa-Mar?́a I, et al. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. Int J Exp Path 2008;89:81-90 (Pubitemid 351365186)
32. Mondragón-Rodr?́guez S, Mena R, Binder LI, et al. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology. Neuropathol Appl Neurobiol 2008;34:62-75
33. Mena R, Luna-Muñoz J. Stages of pathological tau-protein processing in Alzheimer's disease: From soluble aggregations to polymerization into insoluble tau-PHFs. In: Maccione R, Perry G, eds. Current hypothesis and research milestones in Alzheimer's disease. Heidelberg: Springer, 2008:79-91
34. Wang YP, Biernat J, Pickhardt M, et al. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci USA 2007;104:10252-7 (Pubitemid 47175295)
35. Wang Y, Garg S, Mandelkow EM, et al. Proteolytic processing of tau. Biochem Soc Trans 2010;38:955-61
36. Kovacech B, Novak M. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease. Curr Alzheimer Res 2010;7:708-16
37. Guillozet-Bongaarts AL, Glajch KE, Libson EG, et al. Phosphorylation and cleavage of tau in non-AD tauopathies. Acta Neuropathol 2007;113: 513-20 (Pubitemid 46672597)
38. López-González I, Carmona M, Blanco R, et al. Characterization of thorn-shaped astrocytes in white matter of temporal lobe in Alzheimer's disease brains. Brain Pathol 2013;23:144-53
39. Ferrer I, Martinez A, Boluda S, et al. Brain banks: Benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. Cell Tissue Bank 2008;9:181-94
40. Kovacs GG, Rozemuller AJ, van Swieten JC, et al. Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: A study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol 2013;39:166-78.
41. Yoshida M. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 2006;26:457-70 (Pubitemid 44454419)
42. Uchihara T, Nakamura A, Shibuya K, et al. Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains. Brain Pathol 2011;21:180-8
43. Mirra SS, Murrell JR, Gearing M, et al. Tau pathology in a family with dementia and a P301L mutation in tau. Neuropathol Exp Neurol 1999;58: 335-45 (Pubitemid 29187896)
44. Ferrer I, Hernández I, Puig B, et al. Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in p301l tauopathy. J Alzheimers Dis 2003;5: 445-54 (Pubitemid 38101232)
45. Garc?́a-Sierra F, Jarero-Basulto JJ, Kristofikova Z, et al. Ubiquitin is associated with early truncation of tau protein at aspartic acid (421) during the maturation of neurofibrillary tangles in Alzheimer's disease. Brain Pathol 2012;22:240-50
46. Matyash V, Kettenmann H. Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 2010;63:2-10
47. Zhang Y, Barres BA. Astrocyte heterogeneity: An under-appreciated topic in neurobiology. Curr Opin Neurobiol 2010;20:588-94
48. Ramon y Cajal S. Textura del Sistema Nervioso del hombre y de los vertebrados. Madrid: Imprenta y Librer?́a de Nicolás Moya, 1904
49. de Felipe J. Cajal's butterflies of the soul. Oxford: Oxford University Press, 2010
50. Trabzuni D, Wray S, Vandrovcova J, et al. MAPT expression and splicing is differentially regulated by brain region: Relation to genotype and implication for tauopathies. Hum Mol Genet 2012;21:4094-103